Voxelotor
Voxelotor
Voxelotor (pronounced voxe-lo-tor) is a medication used in the treatment of sickle cell disease. It is marketed under the brand name Oxbryta.
Etymology
The name "Voxelotor" is derived from the words "voxel", a unit of graphic information that defines a point in three-dimensional space, and "motor", referring to the drug's mechanism of action in the body.
Usage
Voxelotor is used to treat sickle cell disease, a group of disorders that affect hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. It works by increasing the affinity of hemoglobin for oxygen, thus reducing the sickling of red blood cells.
Related Terms
- Hemoglobin: The protein molecule in red blood cells that carries oxygen from the lungs to the body's tissues and returns carbon dioxide from the tissues back to the lungs.
- Sickle cell disease: A group of disorders that affect hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body.
- Oxbryta: The brand name under which Voxelotor is marketed.
Side Effects
Common side effects of Voxelotor include headache, diarrhea, stomach pain, nausea, fatigue, rash, and fever. More serious side effects can include liver problems and an allergic reaction.
See Also
External links
- Medical encyclopedia article on Voxelotor
- Wikipedia's article - Voxelotor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski